Evaluation of High-Dose Gabapentin Load and Taper Versus Lorazepam Symptom-Triggered Protocol for the Treatment of Alcohol Withdrawal Syndrome in Neurocritical Care Patients

Presenter/Author Information

Kanella Eliadis PharmD, Pharmacy, Advocate Christ Medical Center, Advocate HealthFollow
Kati Khouri PharmD, BCCCP, Pharmacy, Advocate Christ Medical Center, Advocate HealthFollow
Lina Piech PharmD, BCPS, BCCCP, Pharmacy, Advocate Christ Medical Center, Advocate HealthFollow

Recommended Citation

Eliadis K, Khouri K, Piech L. Evaluation of High-Dose Gabapentin Load and Taper Versus Lorazepam Symptom-Triggered Protocol for the Treatment of Alcohol Withdrawal Syndrome in Neurocritical Care Patients. J Patient Cent Res Rev. 2025;12:262. doi: 10.17294/2330-0698.2248

Affiliations

Advocate Christ Medical Center

Presentation Notes

General poster presented at Scientific Day; May 21, 2025; Park Ridge, IL. https://institutionalrepository.aah.org/sciday/2025/general/26

Document Type

Abstract